Knowledge Hub

Pharmaceuticals Report On Partnerships, Licensing, Investments and M&A Deals and Trends for September 2016

Press Release   •   Jan 04, 2017 06:39 EST

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for September 2016 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in September 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

View Full Report at : http://www.marketresearchreports.biz/analysis/879237

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals based on clinical stage of development of products.

- Summary of the pharmaceutical deals globally in the six months.

- Information on the top deals happened in the pharmaceutical industry.

- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Get Sample Copy Of This Report @ http://www.marketresearchreports.biz/sample/sample/879237

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.

- Find out the major deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the market

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

- Identify growth segments and opportunities in each region within the industry.

- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Table Of Content

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 9

2 Pharmaceuticals & Healthcare, Global, Deal Summary, 12

2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, September 2016 12

2.2 Pharmaceuticals & Healthcare, Global, Major Deals, September 2016 14

2.2.1 Shire Raises USD12.1 Billion in Public Offering of Notes 14

2.2.2 Gilead Sciences Raises USD5 Billion in Public Offering of Notes 15

2.2.3 Johnson & Johnson to Acquire Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 15

2.2.4 Sanofi Prices Public Offering of Notes for USD3.3 Billion 16

2.2.5 Allergan to Acquire Tobira Therapeutics in Tender Offer 16

2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, September 2016 19

2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, September 2016 20

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21

3.1 Pharmaceuticals & Healthcare, Global, M&A, September 2016 21

3.1.1 Top M&A Deals in September 2016 22

3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, April 2016 - September 2016 23

3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, September 2016 25

3.2.1 Top Equity Offering Deals in September 2016 26

3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, April 2016 - September 2016 27

3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, September 2016 28

3.3.1 Top PE/VC Deals in September 2016 29

3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, September 2016 30

3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, September 2016 31

3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, April 2016-September 2016 33

3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, April 2016-September 2016 34

3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2016 35

3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, April 2016 - September 2016 37

3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), September 2016 39

3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, September 2016 40

3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), April 2016 - September 2016 41

3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, April 2016 - September 2016 43

3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), April 2016 - September 2016 44

3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), April 2016 - September 2016 46

4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2016 48

4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2016 48

4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2016 50

4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), April 2016 - September 2016 52

4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), April 2016 - September 2016 54

4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), April 2016 - September 2016 56

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.